Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos López-Jiménez
Observed names:
C. López,
Carlos Lopez-Jimenez
Institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Hospital Universitario General de Villalba
Observed institutions:
Hospital General Universitario Gregorio Marañón,
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Hospital Universitario General de Villalba
ORCID:
0000-0001-5864-5117
Observed ORCID:
0000-0001-5864-5117
OpenAlex ID:
A5063164513
Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study
2024
·
Carlos López-Jiménez
, Ana Gutiérrez
, et al.
·
Clinical & Translational Oncology
·
3
Venous thromboembolism incidence in cancer patients with germline BRCA mutations
2021
·
A. J. Muñoz
, M. de Toro
, et al.
·
Clinical & Translational Oncology
·
3
Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor
2024
·
Marta Arregui
, Antonio Calles
, et al.
·
Oncotarget
·
2
PDF
Initial report from the SAR-TRACK (SELNET) registry: a multicentric international retrospective analysis on the quality of the management of limb and trunk wall soft-tissue sarcomas (2012–2022) in Ibero-American countries
2026
·
Javier Martin-Broto
, Victor Castro
, et al.
·
The Lancet Regional Health - Americas
·
1
Primary Cardiac Sarcomas: Clinical Characteristics, Management, and Outcomes at a Spanish National Reference Center
2025
·
Carlos López-Jiménez
, Mónica Benavente de Lucas
, et al.
·
Cancers
·
1
PDF
Evolution of treatment strategies and surgical outcomes in desmoid tumors: A retrospective cohort study
2026
·
Montiel Jiménez-Fuertes
, María Prado-Rivera
, et al.
·
European Journal of Surgical Oncology
Supplementary Table S3 from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Supplementary Table S1 from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Supplementary Table S2 from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Data from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Supplementary Figure S1 from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Supplementary Figure S2 from Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
Plasma ISG15 as predictor of outcome from antiangiogenic therapy in solitary fibrous tumor: Analysis from the GEIS-69 trial.
2026
·
Jose Lucinio Mondaza-Hernandez
, David Silva Moura
, et al.
·
Journal of Clinical Oncology
Prognostic significance of HMGB1 expression as a biomarker of immunogenic cell death in patients with leiomyosarcoma and undifferentiated pleomorphic sarcoma treated with chemo-immuno–based regimens.
2026
·
David Silva Moura
, Jose Lucinio Mondaza-Hernandez
, et al.
·
Journal of Clinical Oncology
PDF
Phase I trial of LB-100 plus doxorubicin as first-line of advanced soft tissue sarcomas: A Spanish Sarcoma Group (GEIS) study.
2026
·
Javier Martin Broto
, Raul Terés
, et al.
·
Journal of Clinical Oncology
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma
2026
·
Javier Martin-Broto
, Javier Martinez-Trufero
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
16
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type